Responses
Clinical/translational cancer immunotherapy
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
